Sharemaestro company-news research for Chocoladefabriken Lindt & Sprüngli AG (LISN), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
EBS
Switzerland
Measured evidence
Company news sentiment
LISN news sentiment
Chocoladefabriken Lindt & Sprüngli AG
Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.
Weighted tone56Neutral is 50
Balanced news tone
71/100 evidence confidence
100% direct company focus
6 current stories across 1 publishers
Current company news
Balanced read
Balanced news tone is drawn from 6 fresh independent stories, including 6 company-specific items across 1 publishers.
Latest source headline Nextensa delivers strong half-year results, supported by several successful transactions finance.yahoo.com · 12 Aug 2026 15:55What supports the read
6 current stories are mapped specifically to LISN.
Cross-story agreement is 85/100, indicating a comparatively coherent tape.
What tempers the read
Only 1 publisher currently contribute to the measured read.
56/100
Weighted toneBalanced news tone
71/100
Evidence confidencesolid confidence
100%/100
Company focus6 direct stories
85/100
Evidence agreement15/100 dispersion
News history
Tone and story flow over 21 days
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50
Evidence confidence
What supports the score
Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.
Sample depth71
5.69 effective storiesSource breadth20
1 independent publishersDirect relevance100
company-specific evidence shareFreshness82
recency-weighted evidenceAgreement85
cross-story consistencySource independence0
lower publisher concentrationPrice context
Sentiment against the 26-week price path
News tone and price action are not far from neutral.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
News subjects
What is shaping the score
Earnings623 stories · 50%
Regulatory and legal591 stories · 17%
Market update581 stories · 17%
Guidance481 stories · 17%
Source mix
Where the evidence comes from
finance.yahoo.com596 stories · 100%
Recurring subjects
Subjects appearing most often
Revenue Growth2Guidance2Earnings2Transactions1Regulation1Real Estate1Quarterly Results1Oncology1Healthcare1Growth Rate1
Earlier readings
How the score has changed
ConstructiveBalanced or withheldCautious
Source headlines
The news behind the score
Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.
#138Tone
finance.yahoo.comDirect company coverage
Nextensa delivers strong half-year results, supported by several successful transactions
Nextensa NV PRESS RELEASE Regulated information Brussels, 12 August 2026, 5:55PM HIGHLIGHTS Nextensadeliversstronghalf-yearresults,supportedbyseveralsuccessful transactions Nextensa achieved strong results in the first half of 2026. The period was marked by several successful transactions, including the sale of Gewerbepark Stadlau in Vienna, the forward sale of The Rock and the sale of B&B Hotels in Cloche d'Or. The granting of the planning and environmental permits for Lake Side in Brussels and the reservation by Vicinity of a substantial residential portion of Bel Towers further underline th
Balance SheetDevelopmentDividendsFinancialsReal EstateTransactions
- Published
- 12 Aug 2026 15:55
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
#259Tone
finance.yahoo.comDirect company coverage
Pierre & Vacances-Center Parcs: Total Number of Shares and Voting Rights
Pursuant to Article L. 233-8 of the French Commercial Code and Article 223-16 of the General Regulations of the French Autorité des marchés financiers PARIS, August 12, 2026--(BUSINESS WIRE)--Regulatory News: Pierre & Vacances-Center Parcs (Paris:VAC): Date Number of shares(*) Number of theoretical voting rights Number of actual voting rights (exercisable at General Meetings) (**) 31 July 2026 462 008 714 462 008 714 461 904 805 (*) Ordinary shares only, i.e. excluding 1,130 preferred shares not admitted to trading. (**) Excluding treasury shares, which are deprived of voting rights (the 1,130
Regulation
- Published
- 12 Aug 2026 13:37
- Catalyst
- Regulatory and legal
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
#348Tone
finance.yahoo.comDirect company coverage
Changes to full-year guidance for BioMar
Aktieselskabet Schouw & Co. Today, BioMar has released an announcement with updated guidance for the full year 2026. BioMar now expects revenue in the range of DKK 17-18 billion against previously DKK 16-17 billion and EBIT in the range of DKK 1,200-1,300 million compared to previously DKK 1,100-1,200 million. BioMar constitutes a material part of the portfolio and is fully consolidated into the Schouw & Co. figures, and the information from BioMar will be incorporated into Schouw & Co.'s guidance. Schouw & Co. provides guidance to the market on revenue and EBITDA and will consider its consoli
Guidance
- Published
- 12 Aug 2026 11:33
- Catalyst
- Guidance
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
#482Tone
finance.yahoo.comDirect company coverage
REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?
The going has been strong for Regeneron Pharmaceuticals REGN over the past month. Shares of this biotech giant have surged 21.9% over the said time frame, outpacing the industry's growth of 4%. The stock has also outperformed the sector and the S&P 500 Index during this time. REGN's robust rally has been driven by better-than-expected quarterly results, which can be attributed to robust demand for Eylea HD (higher dose of Eylea) and higher profit-sharing from Dupixent that helped the company mitigate the decline in Eylea sales. REGN Outperforms Industry, Sector and S&P 500 IndexZacks Investmen
BiotechCompetitionEarningsFda ApprovalOncologyQuarterly Results
- Published
- 11 Aug 2026 14:30
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
#558Tone
finance.yahoo.comDirect company coverage
Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S.
OSLO, Norway, August 11, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the 'Healthcare Resource Utilization and Costs Associated with Blue Light Versus White Light Cystoscopy in Non-Muscle-Invasive Bladder Cancer: A Retrospective Cohort Study' in JU Open Plus this week. The research objective was to evaluate the economic implications of blue light cystoscopy (BLC®) versus white light cystoscopy (WLC) with Hexvix®/Cysview® in a real-world setting, using claims data from the U.S. Optum Research Database. The study authors described the ba
Bladder CancerDiagnosticsHealthcare
- Published
- 11 Aug 2026 06:57
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
#678Tone
finance.yahoo.comDirect company coverage
Rational AG (RATIY) (Q2 2026) Earnings Call Highlights: Record EBIT Margin and Strategic ...
This article first appeared on GuruFocus. Revenue (H1 2026): EUR642 million, up 8% organically and 6% after FX adjustments. Revenue (Q2 2026): EUR324 million, up 4% year-over-year. EBIT (H1 2026): EUR170 million, up 11% year-over-year, with a margin of 26.5% (24.3% excluding tariff refunds). Gross Margin (H1 2026): Improved to 59.8%. Operating Expenses (H1 2026): Increased 5% year-over-year to EUR250 million. iCombi Revenue (H1 2026): EUR562 million, up 5%. iVario Revenue (H1 2026): EUR79 million, up 14%, with North America growing 24%. Germany Revenue (H1 2026): Up 9%. Europe (ex-Germany) Rev
EarningsEBIT MarginGrowth RateGuidanceRevenue GrowthRevenue Growth
- Published
- 11 Aug 2026 01:04
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.